Study to check the efficacy of Uttar Basti (administration of oil through urethra) and oral medicines in the management of Prostate Enlargement
Phase 2
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2022/02/039994
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients diagnosed with BPH Grade I, II or III.
2. Patients having classical signs and symptoms of Mutraghata.
3. Patients fit for Anulomana and Uttara Basti.
Exclusion Criteria
1. Age below 40 years or above 80 years
2. Patients diagnosed with BPH Grade IV
3. Patients with malignancy, congenital deformities of urogenital tract or any pathology other than BPH
4. Patients with Diabetes Mellitus, Hypertension, Renal disorders or any other systemic disease
5. Patients unfit for Anulomana and Uttara Basti
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient is able to maintain normal urine flowTimepoint: 0th Day, 21st Day, 41st Day, 60th Day
- Secondary Outcome Measures
Name Time Method Improvement in International Prostate Symptom Score (IPSS)Timepoint: 0th Day, 21st Day, 41st Day, 60th Day;Reduction in Prostate sizeTimepoint: 0th Day, 60th Day;Reduction in Prostate WeightTimepoint: 0th Day, 60th Day